Epidermal growth factor in patients with schistosomal and/or viral liver diseases and portal hypertension.

M. Abdel Rahman, S. A. Eid, A. Abdel Rahman, G. Nasr, T. A. Morsy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A large number of growth factors have been described and their action and interaction is proving to be complex. The presence study estimated the epidermal growth factor (EGF) in portal hypertension patients with chronic liver disease due to bilharziasis or viral infection as well as in patients with peptic ulcers. The results showed different statistical values regarding liver cirrhosis, oesophageal varices, and bleeding. No doubt, the EGF was indirectly stimulated by the schistosomal and/or viral infection.

Original languageEnglish
Pages (from-to)233-243
Number of pages11
JournalJournal of the Egyptian Society of Parasitology
Volume30
Issue number1
Publication statusPublished - Jan 1 2000
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Epidermal growth factor in patients with schistosomal and/or viral liver diseases and portal hypertension.'. Together they form a unique fingerprint.

  • Cite this